Review article
Kidney Transplantation in High Immunological Risk Recipients
Bojana Maksimović
Full text: croatian pdf 87 Kb
page 213-218
downloads: 203
cite
APA 6th Edition
Maksimović, B. (2023). Kidney Transplantation in High Immunological Risk Recipients. Medicus, 32 (2. Transplantacija), 213-213. Retrieved from https://hrcak.srce.hr/315860
MLA 8th Edition
Maksimović, Bojana. "Kidney Transplantation in High Immunological Risk Recipients." Medicus, vol. 32, no. 2. Transplantacija, 2023, pp. 213-213. https://hrcak.srce.hr/315860. Accessed 22 Nov. 2024.
Chicago 17th Edition
Maksimović, Bojana. "Kidney Transplantation in High Immunological Risk Recipients." Medicus 32, no. 2. Transplantacija (2023): 213-213. https://hrcak.srce.hr/315860
Harvard
Maksimović, B. (2023). 'Kidney Transplantation in High Immunological Risk Recipients', Medicus, 32(2. Transplantacija), pp. 213-213. Available at: https://hrcak.srce.hr/315860 (Accessed 22 November 2024)
Vancouver
Maksimović B. Kidney Transplantation in High Immunological Risk Recipients. Medicus [Internet]. 2023 [cited 2024 November 22];32(2. Transplantacija):213-213. Available from: https://hrcak.srce.hr/315860
IEEE
B. Maksimović, "Kidney Transplantation in High Immunological Risk Recipients", Medicus, vol.32, no. 2. Transplantacija, pp. 213-213, 2023. [Online]. Available: https://hrcak.srce.hr/315860. [Accessed: 22 November 2024]
Full text: english pdf 87 Kb
page 213-213
downloads: 153
cite
APA 6th Edition
Maksimović, B. (2023). Kidney Transplantation in High Immunological Risk Recipients. Medicus, 32 (2. Transplantacija), 213-213. Retrieved from https://hrcak.srce.hr/315860
MLA 8th Edition
Maksimović, Bojana. "Kidney Transplantation in High Immunological Risk Recipients." Medicus, vol. 32, no. 2. Transplantacija, 2023, pp. 213-213. https://hrcak.srce.hr/315860. Accessed 22 Nov. 2024.
Chicago 17th Edition
Maksimović, Bojana. "Kidney Transplantation in High Immunological Risk Recipients." Medicus 32, no. 2. Transplantacija (2023): 213-213. https://hrcak.srce.hr/315860
Harvard
Maksimović, B. (2023). 'Kidney Transplantation in High Immunological Risk Recipients', Medicus, 32(2. Transplantacija), pp. 213-213. Available at: https://hrcak.srce.hr/315860 (Accessed 22 November 2024)
Vancouver
Maksimović B. Kidney Transplantation in High Immunological Risk Recipients. Medicus [Internet]. 2023 [cited 2024 November 22];32(2. Transplantacija):213-213. Available from: https://hrcak.srce.hr/315860
IEEE
B. Maksimović, "Kidney Transplantation in High Immunological Risk Recipients", Medicus, vol.32, no. 2. Transplantacija, pp. 213-213, 2023. [Online]. Available: https://hrcak.srce.hr/315860. [Accessed: 22 November 2024]
Abstract
HLA (Human Leucocyte Antigen) sensitization is a significant barrier to successful kidney transplantation. It often leads to prolonged waiting time on transplant lists and significantly increased morbidity and mortality. Over the last decade new technologies of HLA antibody identification have emerged, as well as several immunomodulatory therapies allowing for increased access to kidney transplantation for the immunologically disadvantaged group of HLA sensitized end-stage kidney disease patients. Also, a different allocation program was introduced in order to prioritize these groups of patients. Still there is an unmet need for more efficient and safer therapies to avoid HLA sensitization. The collaboration of transplant physicians, immunologists, and pharmaceutical industries is crucial to delineate a path forward to improve access to kidney transplantation.
Keywords
kidney transplantation; HLA sensitization; HLA antibodies
Hrčak ID:
315860
URI
https://hrcak.srce.hr/315860
Publication date:
9.4.2024.
Article data in other languages:
croatian
Visits: 835
*
